vaccines
DomesticBiological Product
Recombinant Lispro Insulin Injection
甘李药业股份有限公司
Drug Information
| Generic name | 重组赖脯胰岛素注射液 |
|---|---|
| English name | Recombinant Lispro Insulin Injection |
| Dosage form | Injection |
| Specification | 3ml:300单位/支(笔芯) |
| Category | Biological Product |
| Approval no. | 国药准字S20063004 |
| Drug code | 86900227000039 |
| Manufacturer | 甘李药业股份有限公司 |
| Production address | 北京市通州区漷县镇南凤西一路8号 |
| Origin | Domestic |
| Approval date | 2020-11-16 |
Source: NMPA (National Medical Products Administration) drug registration data, for reference only. This page does not include dosage or indications; follow your doctor's advice and read the package insert.